Janney Montgomery Scott LLC Cara Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$12.72 - $16.16 $149,002 - $189,298	-11,714 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$12.34 - $17.92 $16,659 - $24,192	-1,350 Reduced 10.33%	11,714 $149,000
Q2 2020 Jul 23, 2020	SELL	$12.39 - $17.33 $1,858 - $2,599	-150 Reduced 1.14%	13,064 $223,000
Q1 2020 Apr 30, 2020	SELL	$9.12 - $17.78 $48,655 - $94,856	-5,335 Reduced 28.76%	13,214 $175,000
Q4 2019 Jan 21, 2020	SELL	$16.11 - $25.98 $36,456 - $58,792	-2,263 Reduced 10.87%	18,549 $299,000

Q3 2019 Oct 29, 2019	SELL	$18.28 - $26.91 $8,427 - $12,405	-461 Reduced 2.17%	20,812 $380,000
Q2 2019 Jul 29, 2019	SELL	$17.68 - $21.57 $60,518 - $73,834	-3,423 Reduced 13.86%	21,273 $457,000
Q1 2019 Apr 30, 2019	SELL	$14.41 - $19.64 $60,983 - $83,116	-4,232 Reduced 14.63%	24,696 $485,000
Q4 2018 Feb 01, 2019	SELL	$12.45 - $23.47 $21,165 - $39,899	-1,700 Reduced 5.55%	28,928 $376,000
Q3 2018 Nov 05, 2018	BUY	$17.57 - $23.95 $13,230 - $18,034	753 Added 2.52%	30,628 $734,000
Q2 2018 Jul 24, 2018	SELL	$11.6 - $19.27 $52,200 - $86,715	-4,500 Reduced 13.09%	29,875 $572,000
Q1 2018 Apr 19, 2018	SELL	$11.77 - $16.08 $269,580 - $368,296	-22,904 Reduced 39.99%	34,375 $426,000
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $425,940 - $505,669	35,914 Added 168.1%	57,279 $701,000
Q3 2017 Nov 15, 2017	BUY	$12.6 - $16.34 $269,199 - $349,104	21,365	21,365 $292,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.